0.3400CADMkt Cap: 24.18M CADP/E: 34.00Last update: 2026-05-21
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. The company offers NexSys claims…
Industry Peers
Health Information Services6.87BSEKP/E 30.6
4.76BTRYP/E 4.7
1.91BSEKP/E 36.3
1.58BSEKP/E 40.7
556.94MEURP/E 14.3
495.75MGBpP/E 30.8
426.97MEURP/E 26.4
264.51MNOKP/E 59.2
loading…
Indicators:|
Key Statistics
Company
Market Cap24.18M CAD
Enterprise Value21.42M CAD
Revenue (TTM)17.93M CAD
Gross Profit14.93M CAD
Net Income (TTM)1.29M CAD
Revenue/Share0.2520 CAD
Last Price0.3400 CAD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryCA
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)34.00
P/E (Forward)—
PEG6.53
EV/EBITDA8.71
EV/Revenue1.19
P/S1.35
P/B4.05
EPS (TTM)0.01
EPS (Forward)—
52W Range
—
52W High0.3400 CAD
52W Low0.3400 CAD
Profitability
Gross Margin83.28%
Oper. Margin16.63%
EBITDA Margin13.72%
Profit Margin7.19%
ROE16.92%
ROA3.52%
Growth
Revenue Growth5.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF4.98M CAD
CapEx (TTM)345.03K CAD
FCF Margin21.69%
FCF Yield16.09%
Net Debt-4.41M CAD
Net Debt/EBITDA-1.79
Balance Sheet
Debt/Equity0.05
Current Ratio1.13
Quick Ratio0.19
Book Value/Sh0.0840 CAD
Cash/Share0.0670 CAD
Dividends
Fwd Div Rate0.0100 CAD
Trail. Div Rate0.0150 CAD
Div. Yield2.94%
5Y Avg Yield—
Payout Ratio107.14%
Ex-Div DateApr 24, 2026
Pay DateApr 28, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.71.12M
Float44.82M
Insiders36.97%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Out.0.00%
Shares Short185
Short (prev mo.)686
Technical
SMA 500.3630 (-6.3%)
SMA 2000.3761 (-9.6%)
Beta0.45
S&P 52W Chg28.31%
Avg Vol (30d)1.00K
Avg Vol (10d)16.62K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—